BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11730166)

  • 1. Safety and efficacy of an oil-adjuvant vaccine against haemorrhagic septicaemia in buffalo calves: cross-protection between the serotypes B:2,5 and E:2,5.
    Shah NH; Jacobs AA; Shah NH; de Graaf FK
    Vet Rec; 2001 Nov; 149(19):583-7. PubMed ID: 11730166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.
    Hodgson JC; Finucane A; Dagleish MP; Ataei S; Parton R; Coote JG
    Infect Immun; 2005 Mar; 73(3):1475-81. PubMed ID: 15731045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, efficacy and cross-protectivity of a live intranasal aerosol haemorrhagic septicaemia vaccine.
    Myint A; Jones TO; Nyunt HH
    Vet Rec; 2005 Jan; 156(2):41-5. PubMed ID: 15675522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against haemorrhagic septicaemia induced by vaccination of buffalo calves with an improved oil adjuvant vaccine.
    Shah NH; Shah NH; de Graaf FK
    FEMS Microbiol Lett; 1997 Oct; 155(2):203-7. PubMed ID: 9351202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intranasal vaccination of field buffaloes against haemorrhagic septicaemia with a live gdhA derivative Pasteurella multocida B:2.
    Rafidah O; Zamri-Saad M; Shahirudin S; Nasip E
    Vet Rec; 2012 Aug; 171(7):175. PubMed ID: 22815208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of haemorrhagic septicaemia in buffaloes and cattle with a live vaccine.
    Myint A; Carter GR
    Vet Rec; 1989 May; 124(19):508-9. PubMed ID: 2502878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to haemorrhagic septicaemia (HS) vaccination in Trypanosoma evansi infected buffalo-calves.
    Singla LD; Juyal PD; Sharma NS
    Trop Anim Health Prod; 2010 Apr; 42(4):589-95. PubMed ID: 19784863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immune response and duration of protection in buffaloes immunized with haemorrhagic septicaemia vaccines.
    Chandrasekaran S; Kennett L; Yeap PC; Muniandy N; Rani B; Mukkur TK
    Vet Microbiol; 1994 Aug; 41(3):213-9. PubMed ID: 7975147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between active protection in vaccinated buffaloes against haemorrhagic septicaemia and passive mouse protection test or serum antibody titres.
    Chandrasekaran S; Kennett L; Yeap PC; Muniandy N; Rani B; Mukkur TK
    Vet Microbiol; 1994 Aug; 41(4):303-9. PubMed ID: 7801530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.
    Dagleish MP; Hodgson JC; Ataei S; Finucane A; Finlayson J; Sales J; Parton R; Coote JG
    Infect Immun; 2007 Dec; 75(12):5837-44. PubMed ID: 17875632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary field trails with a streptomycin-dependent vaccine against haemorrhagic septicaemia.
    De Alwis MC; Carter GR
    Vet Rec; 1980 May; 106(21):435-7. PubMed ID: 6776679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of
    Fegan JE; Waeckerlin RC; Tesfaw L; Islam EA; Deresse G; Dufera D; Assefa E; Woldemedhin W; Legesse A; Akalu M; Bayissa B; Nguyen QH; Ng D; Ahn SK; Schryvers AB; Tefera TA; Moraes TF; Gray-Owen SD
    Front Immunol; 2024; 15():1392681. PubMed ID: 38835751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of outer membrane protein of Pasteurella multocida in buffalo calves.
    Pati US; Srivastava SK; Roy SC; More T
    Vet Microbiol; 1996 Oct; 52(3-4):301-11. PubMed ID: 8972056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection, humoral and cell-mediated immune responses in calves immunized with multiple emulsion haemorrhagic septicaemia vaccine.
    Verma R; Jaiswal TN
    Vaccine; 1997 Aug; 15(11):1254-60. PubMed ID: 9286053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological evaluation of Pasteurella multocida antigens associated with protection in buffalo calves.
    Afzal M; Muneer R; Akhtar S
    Rev Sci Tech; 1992 Sep; 11(3):917-23. PubMed ID: 1472736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of experimental haemorrhagic septicaemia with a live vaccine.
    Myint A; Carter GR; Jones TO
    Vet Rec; 1987 May; 120(21):500-1. PubMed ID: 3111071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host responses and bacterial colonization following inoculation of Pasteurella multocida P
    Singh M; Verma R; Pandit RS; Tarfain NU
    Microb Pathog; 2017 Oct; 111():269-273. PubMed ID: 28888883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ABA392/pET30a protein of Pasteurella multocida provoked mucosal immunity against HS disease in a rat model.
    Kang TL; Velappan RD; Kabir N; Mohamad J; Rashid NN; Ismail S
    Microb Pathog; 2019 Mar; 128():90-96. PubMed ID: 30584901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B:2.
    Ataei S; Burchmore R; Christopher Hodgson J; Finucane A; Parton R; Coote JG
    Res Vet Sci; 2009 Oct; 87(2):207-10. PubMed ID: 19243798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three oil-adjuvant vaccines against Pasteurella multocida in buffalo calves.
    Muneer R; Akhtar S; Afzal M
    Rev Sci Tech; 1994 Sep; 13(3):837-43. PubMed ID: 7949356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.